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ABSTRACT A model of fibrinolysis was developed using multicomponent convection-diffusion equations with homogeneous
reaction and heterogeneous adsorption and reaction. Fibrin is the dissolving stationary phase and plasminogen, tissue plas-
minogen activator (tPA), urokinase (uPA), and plasmin are the soluble mobile species. The model is based on an accurate
molecular description of the fibrin fiber and protofibril structure and contains no adjustable parameters and one phenomeno-
logical parameter estimated from experiment. The model can predict lysis fronts moving across fibrin clots (fine or coarse fibers)
of various densities under different administration regimes using uPA and tPA. We predict that pressure-driven permeation is
the major mode of transport that allows for kinetically significant thrombolysis during clinical situations. Without permeation, clot
lysis would be severely diffusion limited and would require hundreds of minutes. Adsorption of tPA to fibrin under conditions
of permeation was a nonequilibrium process that tended to front load clots with tPA. Protein engineering efforts to design optimal
thrombolytics will likely be affected by the permeation processes that occur during thrombolysis.
INTRODUCTION
The biochemistry of thrombolytic therapy for the treatment
of acute myocardial infarction has been the subject of in-
tensive study. Plasminogen activators such as tissue plas-
minogen activator (tPA), urokinase (uPA), or streptokinase
(SK) are all currently used clinically to convert plasminogen
to plasmin. Plasmin proteolytically degrades the fibrin of the
blood clot leading to thrombolysis. A challenge with this type
of therapy is the need for rapid reperfusion balanced against
the risk of systemic bleeding. With successful thrombolysis,
reperfusion times vary from about 20 to 80 min. Generally,
about 80 mg of tPA or 106 IU (-90 mg) of uPA is admin-
istered IV, or about 20 mg of tPA or 0.5 X 106 IU (-45 mg)
of uPA is administered locally via catheter over a 1-h period
for acute myocardial infarction (Physicians' DeskReference,
1992).
The structures of real blood clots are extremely compli-
cated and variable. During platelet activation, prothrombin is
activated to thrombin which then cleaves the negatively
charged fibrinopeptides A and B from the central E domain
(NH2 terminals of a and f chains) of fibrinogen, yielding an
active fibrin monomer. This monomer rapidly polymerizes
end-to-end to form protofibrils of staggered arrangement (for
a review, see Doolittle, 1984; and more recently, Weisel and
Nagaswami, 1992; Hunziker et al., 1990). The protofibrils
can also aggregate side-to-side to form fibers with diameters
of about 100 to 500 nm (Carr et al., 1977; Carr and Hermans,
1978; Blomback and Okada, 1982; Blomback et al., 1989;
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Weisel and Nagaswami, 1992) under physiological condi-
tions. Entrapped platelets can retract the fibrin to about a
tenth of the original volume by squeezing plasma from the
clot. Clot retraction occurs if the clot boundary is allowed to
move. Otherwise an isometric force is generated on the fixed
boundary by the clot (Jen and McIntire, 1986). Retracted
clots are particularly resistant to fibrinolytic degradation
(Sabovic et al., 1989) possibly due to the reduction of the
fluid phase plasminogen in the clot. Arterial thrombi which
can be flow-compacted may contain an even more dense
network of fibrin. Thrombin-activated Factor XIIIa can
crosslink the protofibrils and fibers through transamidase ac-
tivity which catalyzes the formation of E-(,y-glutamyl)lysine
bonds between a chains or -y chains of adjacent fibrin mono-
mers to yield a-polymers and y-dimers. Under physiological
conditions, the y--y crosslinks are formed at a faster rate than
the a-a crosslinks. During lysis of the fibrin gels many dif-
ferent fibrin degradation products are produced. In non-
crosslinked gels, the intermediate X and Y fragments can be
degraded further to E and D fragments, while in crosslinked
gels, fragments contain significant quantities of D-D dimers.
The physical and biochemical structure of the fibrin clot
depends upon the polymerization conditions such as the
thrombin concentration, the fibrinogen concentration, the
ionic strength of the solution phase, and the hemodynamic
environment (Carr et al., 1977; Weisel and Nagaswami,
1992). The gel structure is made of long fibrin fibers with
relatively uniform diameters. Branching is often observed
(Blomback et al., 1989). Fibrin gels formed under low ionic
strength (0.1 mM) display more lateral aggregation of pro-
tofibrils compared to those formed under high ionic condi-
tions (0.3 mM) which kinetically favors protofibril exten-
sion. The fiber diameter is thick (100-500 nm) in coarse gels
formed at low ionic strength, while fine gels formed at high
ionic strength have a typical fiber diameter of about 8 to 100
nm. Also, the specific permeability is much higher in coarse
gels of clotted plasma (k - 10-8 cm2) than in fine gels of
clotted plasma (k - 1010 cm2) (Carr et al., 1977; Carr and
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Hardin, 1987; Blomback et al., 1989). In flow-compacted
coarse fibrin (-220 ,iM fibrin; porosity - 0.75), the specific
permeability may be as low as 10-11 cm2 or less. The ef-
fective pore diameter is on the order of a few microns (3 to
10 ,um) in coarse gels of clotted plasma, while the pore di-
ameter may be as low as 0.1 to 0.5 ,um in fine gels. In purified
fibrin gels or retracted blood clots, the pore diameters are
relatively large and are not expected to hinder the Brownian
motion of soluble proteins (Brenner and Gaydos, 1977; Blum
et al., 1989; Phillips et al., 1990; Matveyev and Domogatsky,
1992).
The intent of the present work was to study the impact of
inner clot transport phenomena on the fibrinolytic system.
The diffusion of proteins through polymeric gels such as
fibrin is a relatively slow process compared to permeation.
In the absence of fluid permeation through the clot, the lysis
front moving across a clot cannot proceed faster than dif-
fusion. Hundreds of hours would be required for a protein to
diffuse a distance of 1 cm. If the therapeutic dose of 1.0 mg
of tPA were instantaneously distributed and bound to a 1-ml
clot (formed from 3 mg of fibrinogen) which contained 0.075
,uM plasminogen (typical clot-bound concentration) over
99% of the plasminogen would be converted to plasmin
within a few seconds. Yet for moderately sized clots, sub-
stantial lysis does not occur on a time scale of seconds or a
few minutes. It is likely that rate limits involved in plas-
minogen activation, plasmin degradation of fibrin, and trans-
port of plasminogen activators into a clot can prolong the
time needed to reperfuse a vessel during thrombolytic
therapy. The present study has sought to develop a realistic
model of the fibrinolytic pathways in order to identify rate-
limiting steps during thrombolytic therapy. The limits of
transport likely play an important role in controlling clot
lysis.
MODEL FORMULATION
To model the process of fibrinolysis, we have used a system
of multicomponent convection-diffusion transport equations
with homogeneous reaction and heterogeneous adsorption
and reaction (Bird et al., 1960; Rubin, 1983; Kirkner et al,
1984; Whitaker, 1987). The species considered are: tPA, uro-
kinase, plasminogen (glu- or lys-plasminogen), plasmin, and
fibrin. These species can reside in either the fluid phase or
the fibrin phase of the clot. During the simulations of fibri-
nolysis, the structural properties of the fibrin evolve in time
as the clot is degraded.
Convective transport properties
Little is known about the diffusive and convective transport
of proteins through real blood clots. Permeation (also termed:
advection, convection, or perfusion) through fibrin is de-
scribed accurately by Darcy's Law (Eq. 1) for slow, unidi-
rectional flow where the flow rate Q (cm3/s) per cross-
sectional area A (cm2) is proportional to the pressure drop
AP/L (dyne/cm' per cm-clot) across the clot (Carr et al.,
1977; Blomback et al., 1989). No specific permeability data
is available for actual platelet-contracted, flow-compacted
blood clots which contain layers of fibrin, platelets, and red
blood cells. Using nominal values for a coronary blood clot
(AP/L - 60 mm Hg/cm-clot or 8 X 104 dyne/cm2 per cm-
clot), the superficial velocity v may be as high as 0.001 cm/s.
Darcy's Law v = Q -G)L (1)
The specific permeability of a fibrous medium is often cor-
related with the overall porosity and a length scale of the
microstructure such as fiber diameter. We have found that the
Davies' equation (Dullien, 1979) (Eq. 2) accurately corre-
lated the data of Blomback (1989) for permeability mea-
surements made on fibrin gels polymerized under various
thrombin concentrations and ionic strengths. In their study,
the overall fibrin porosity was calculated by Blomback et al.
(1989) for hydrated fibrin strands while the fiber diameter
was determined by three-dimensional confocal microscopy
and permeation experiments.
Davies' Equation
70(1k- ){1=+52(1f-iberk=70(1- E)3/211 + 52(1- E)3/2} (2)
In uniform fibrin gels, viscous fingering is not expected since
the permeating buffer or plasma has nearly the same viscosity
as the plasma being displaced from the interstitial regions of
the clot. However, the nonisotropic nature of real clots, with
layers of platelet-rich and platelet-poor regions generated
during the formation of the clot, may lead to preferred chan-
nels of perfusion. Retracted platelet-rich regions of the clot
which are resistant to flow can direct fluid through more
permeable regions of the clot. This spatial variations in clots
has been described histologically (lines of Zahn), however
this type of clot heterogeneity has not been considered in the
present work.
Diffusive/dispersive transport properties
In general, the diffusion of proteins within polymeric gels
can be altered by solvent viscosity q and molecular caging
by the polymer strands. Since the porosity of pure fibrin is
high (E> 0.90), excluded volume effects are expected to be
small. Typically, hindered diffusion occurs when the hydro-
dynamic radius of the protein ri exceeds about 0.3 of the
effective pore radius rpore (Brenner and Gaydos, 1977; Blum
et al., 1989; Phillips et al., 1990). The volume-averaged,
effective diffusion coefficient of the ith species in fibrin is
given as
D fibrin = funct( r ) ( -)
rpore )7plasma (3)
where funct(rJ/rpore) = 1 for ri/rpore < 0.3 and t7 is the
diffusion coefficient of the ith species in water. In coarse
gels, the effective pore diameter is about 1 to 5 gm; the
correction factor for hindered diffusion is equal to one since
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the hydrodynamic radius of most proteins is under 20 nm. In
fine gels formed under high ionic strength conditions, the
pore radius is as small as 100 nm and a slight hindrance of
diffusion of large soluble proteins could occur. In the present
work, the correction factor for hindrance is set to unity in
agreement with recent studies of protein penetration into re-
tracted clots (Matveyev and Domogatsky, 1992; Park et al.;
1988).
Due to binding interaction with the fibrin network, a pro-
tein can display an apparent diffusion much lower than that
expected for the protein in a pure plasma phase. Even in the
presence of fluid permeation, this binding interaction can
severely retard the movement of a protein. Binding interac-
tions of the protein with the fibrin are treated in the overall
governing equations of transport (not in Eq. 3) since binding
interactions need not be at local equilibrium. This approach
allows physical processes (Brownian motion) to be de-
coupled from biochemical processes such as adsorption and
desorption. Strong fibrin binding by a protein will lead to
reduced transport as a result of the adsorption terms in the
governing equations (Kaufman and Jain, 1990).
With the effective diffusion coefficient containing the ap-
propriate physics, it is possible to define the axial dispersion
coefficient which is the sum of molecular diffusion and
convection-enhanced mixing across fluid streamlines. Sa-
himi et al. (1986) describe dispersion as a process occurring
in macroscopically homogeneous, microscopically heterog-
eneous media due to (i) molecular diffusion, (ii) irregular
flow paths and mixing through a complex geometry, and (iii)
a kinetic mechanism from changing flow speeds in a complex
geometry. The tortuosity factor of a fibrous gel of such high
porosity as fibrin is estimated to be near unity since fibrin
gels have a well-connected pore space. Also, stagnation ef-
fects in dead zones are not expected to contribute to the
dispersion in uniform fibrin gels because of the well-
connected pore space. For this type of dispersion, a common
form of the longitudinal dispersion coefficient is DL = az LZ
v13, where ao is a geometric parameter typically set to unity,
LZ is a characteristic length scale of the microscopic media
(such as pore diameter, Dpore), and v is the superficial ve-
locity (Sahimi et al., 1986). The exponent ,B is found ex-
perimentally to be between 1 and 2 for most materials, and
is set to unity in this work for aperiodic, randomly oriented,
fibrous media. Using this formulation, the dispersion coef-
ficient is given in Eq. 4 as a combination of the effective
diffusion coefficient and axial dispersion. The contribution
of Brownian motion to the dispersion is small when perme-
ation occurs. The Peclet number (Pe) based on the dispersion
coefficient is given as PeL = v - L/DL and can range nomi-
nally from zero to an order of 103 for arterial thrombi. The
complex effects of adsorption and reaction on the dispersion
coefficient are not considered since dispersive phenomena
has a relatively smaller contribution toward overall fibrino-
lysis for PeL > 1.
DL iibin= Debri + DporeV (4)
Protein adsorption
When considering an appropriate description for the adsorp-
tion of molecules from the plasma phase of a fibrin gel on
to the actual fibers of the fibrin, each species must be con-
sidered individually. In general, adsorption can be: (i) at local
equilibrium between the fluid and fibrin phase, (ii)
kinetically-controlled by the forward and reverse rate of ad-
sorption and desorption, or (iii) controlled by mass transfer
limits across stagnant boundary layers (Rubin, 1983).
In situations of significant permeation, the strong connec-
tivity of fibrin structures (especially in purified fibrin gels)
would produce liquid convection through much of the pore
space with little space remaining unperfused. Very near fiber
strands, domains may exist which are poorly mixed. Al-
though the pore size in clots and gels is relatively large (on
the order of a micron) and does not significantly hinder dif-
fusion (Matveyev and Domogatsky, 1992), the time neces-
sary for a protein to diffuse across a pore is relatively small.
For a typical protein with a diffusion coefficient of 5 X 10-
cm2/s in the water phase of the gel, it would require a char-
acteristic time well under a second to move across the pore.
A stagnant film at the fiber surface is unlikely to pose much
of a limit on transport since diffusion can achieve mixing on
lengths of a micron and times of a second. More formally,
in the worst case scenario in a gel pore with maximum for-
ward rate adsorption to fully available sites {max. forward
rate = (kf Oj) * Cbulk} with transport only by Brownian mo-
tion, the Damkohler number (NDa = [(kf Oj) Dpore2/Dieff] 1/2)
is less than 0.01 for plasminogen, plasmin, and tPA adsorp-
tion to fibrin. For NDa < 0.1, adsorption phenomena is ki-
netically controlled and is not diffusionally controlled (Bis-
choff, 1965). Thus, when applying continuum models to
understand adsorption during fibrinolysis, it is an accurate
approach to assume kinetically-controlled adsorption. If the
forward and reverse rates of adsorption are high and of simi-
lar magnitude, then the kinetically-controlled adsorption for-
mulation would result in local equilibrium.
We model the kinetically controlled adsorption of a
soluble species to fibrin by a second order forward rate con-
stant (kf, puM-1 s-1) describing the association between free
solute and available binding sites. Available binding sites are
defined as the total concentration of the ith site Oi minus the
concentration of these site which are filled. A first order
reverse rate constant (k,r s-1) describes the dissociation of
bound species. The net rate of change of bound concentration
of the ith species is
= kfC (0i Cb) krCb
at ,f I
The parameters for the adsorption of tPA, plasminogen and
plasmin are given in Table 1. At a given position in the clot,
the bound concentration cb is defined as the moles of the ith
species contained within the local fibrin solid phase volume.
For equilibration with fibrin of the ith species at ci(o) initially
in the fluid phase, conservation of mass requires that cf +
(5)
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TABLE 1 Summary of kinetic parameters for the reversible adsorption and desorption of plasminogen (pig) and tissue
plasminogen activator (tPA) to fibrin
Reversible adsorption Kinetic constants Reference
fbn + plgf = plgb glu-plasminogen Lucas, et a. (1983)
Kd = 38 ,uM (qglu-plg = 2.0 sites/monomer)
kf = 1.087 X 10- jM1s' *
kr = 4.131 x 10-3 S-1
lys-plasminogen Lucas, et al. (1983)
Kd = 0.5 ,uM (qlys-plg = 2.4 sites/monomer)
kf = 1.087 x 10-4 /jM-lS-1*
kr = 5.435 X 10-5 s-'
tbn + plmf p1mb glu-plm or lys-plasmin Suenson & Thorsen (1981)
Kd = 0.5 ,uM (qplm = 2.0 sites/monomer)
kf = 1.087 x 10-4 gM-1S-M t
kr = 5.435 X 10-5 S-1
tbn + tpaf tpab kd = 0.58 ,iM Husain, et al. (1989)
kf = 1.148 X 10-4 IM_ S (qlpa - 1.5 sites/monomer)
kr = 6.658 x 10-5 S-q
Urokinase was assumed to have no binding interaction with fibrin (f = free, b = fibrin bound).
* Calculated for 1.65 ,uM of free lys-plasminogen binding to dispersed (sonicated) fibrin which required a time of 10 minutes to reach equilibrium (Lucas,
et al., 1983). It was assumed that glu-plasminogen binds fibrin at the same forward rate as lys-plasminogen. Other reports of plasminogen binding to
undispersed fibrin (Bok and Mangel, 1985; Sobovic, et al., 1990) that estimated the time to reach equilibrium to be between 4 to 16 h may contain significant
diffusion limited phenomena due to the dense structures and long diffusion lengths. We have assumed that all plasminogen binding sites are available in
dispersed fibrin.
* Plasmin (either glu-plm or lys-plm) was assumed to complex with fibrin at a forward rate similar to lys-plasminogen binding. This is in part justified by
the similar Kd found experimentally for active site-inhibited glu-plasmin and lys-plasmin binding to fibrin (Suenson and Thorsen, 1981).
§ Estimated for 0.005 to 0.75 ,uM of free single chain tPA binding to 0.135 ,uM of dispersed (sonicated) crosslinked fibrin which required a time of 15 min
to reach equilibrium. We have assumed that all tPA binding sites are available in the dispersed fibrin.
[(1 - E)/E]c' = ci(o). Note, however, that cf + C' 7 Cj(O)
in this formulation due to the definition of c'.
Fibrin structure during lysis
Some idealization of the fibrin structure, either in real clots
or purified fibrin gels, is needed in order to relate local, in-
stantaneous reaction rates to the evolution of the fibrin struc-
ture during lysis. As the fibrin structure undergoes lysis, the
void volume (plasma phase) increases. By modeling the evo-
lution of the average local fiber diameter as a function of the
local lysis history, it is possible to relate the transport phe-
nomena with the time and space dependent reactions. We
model the lysis of the fibrin fiber as a process where plasmin-
mediated lysis moves from the outside of the fiber inward,
reducing the fiber diameter as lysis proceeds (Fig. 1 A). As
the clot is lysed, the fiber diameter decreases, while the po-
rosity and subsequently the specific permeability (see Eq. 2)
increase. This assumption is justified by the work of Gabriel
(1992) which showed the mass-to-length ratio to decrease
with time of lysis. However, coarse fibers are known to un-
dergo substantial inner fiber lysis before breakup (Carr et al.,
1992). To adequately model both surface and inner fiber lysis
would be very difficult and would require: (i) the definition
of an inner fiber free and inner fiber bound concentrations as
a function of fiber radial position, axial clot distance, and
time; (ii) prediction of inner fiber diffusion coefficients; and
(iii) simultaneous solution of the radial diffusion/adsorption/
reaction equations (in cylindrical coordinates for the fiber)
coupled with global transport equations. Our approach takes
A
0 0
00
50%Ilysis
0
0
90 % lysis
B
protofibnl
fiber
FIGURE 1 (A) Schematic model depicting the dissolving of fibrin fibers
by plasmin degradation. As the fibers are lyzed, the diameter of the fiber
decreases while the length of the fiber remains constant, i.e. lysis of the fiber
proceeds radially inward. (B) Each fiber is a bundle of many protofibrils.
The protofibril is a staggered arrangement of fibrin monomers. Protofibrils
on the outer surface of the fiber specifically bind soluble species such as tPA,
plasminogen, and plasmin. In the present work, the surface concentration
of binding sites and cleavable fibrin sites is calculated from the number of
protofibrils on the outer surface of the fiber.
no account of the branching and crosslinked nature of fibrin,
thus rheological information about the elasticity of the gel
during lysis is not recovered.
In order to characterize the available binding sites for tPA,
plasminogen and plasmin, only protofibrils on the outside of
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the fiber were considered sterically accessible for binding of
soluble proteins (Fig. 1 B). To describe plasminogen acti-
vation and plasmin degradation events localized at the sur-
face of the fibrin fibers, it was necessary to evaluate the
number of protofibrils exposed on the outside of each fiber.
The concentration (0, ,uM) of binding sites and lytic sites
was then related to the number of protofibrils sterically ac-
cessible, the number of fibrin monomers per unit length of
fibril (about 2 monomers/45 nm or 1.5 X 1011 Da/cm) (Carr
et al., 1977; Hunziker et al., 1990), and number of individual
sites per monomer (qi). In this approach of steric accessi-
bility, the tPA and plasminogen adsorption rates are depend-
ent on the available binding sites on the outside of each fiber.
Also, the kinetic description of plasmin degradation is de-
pendent on the number of available degradation sites on the
outside of each fiber undergoing lysis. As the clot degrades
the number of available sites per unit volume decreases.
To calculate the number of protofibrils on the outside of
a given fiber of radius, Rf, we assumed that the protofibrils
randomly pack with no overlap to yield a final fiber porosity
of Efiber = 0.80 and a final fiber density of 0.28 gr-fibrin/
ml-fiber (Carr and Hermans, 1978). Using this experimen-
tally determined fiber density, the protofibril probability den-
sity, po = number of fibrils per cross-sectional area of fiber
= NJ(wRf2) is given as: po = 0.01116 fibrils per nm2 of fiber
cross-section (see Appendix). This corresponds to 197 pro-
tofibrils in a 150 nm diameter fiber which is consistent with
Weisel and Nagaswami (1992). This approach segregates the
water in the molecular interstitial regions of the protofibril
as part of the void volume of the fiber and not part of the
protofibril volume. We evaluated the average number of
outer fibrils, m(r), lying at or on the outer radius Rf (Eq. 6).
A value of ro = 2.39 nm was used as the average radius of
the protofibril which yields a fiber porosity of 0.8 and fiber
density of 0.28 gr-fibrin/ml-fiber.The radius of a hydrated
protofibril which includes bound water is about 3 to 5 nm.
Also, we calculated the number of fibrils, N enclosed within
a given fiber radius (Eq. 7) or, inversely, the fiber radius Rf
of a bundle of N protofibrils (Eq. 8). See Appendix for de-
tails.
m(Rf), no. of outer protofibrils on Rf = [47rp.ro] * Rf (6)
N(Rf), no. of protofibrils within Rf = [np.] _ (Rf)2 (7)
Rf, radius of fiber = [ip] 1/2 * (N')1/2 (8)
This approach allows the formulation of intrinsic kinetics and
adsorption phenomena on an available site basis, instead of
macroscopic volume-averaged site concentrations which
may not be valid for fibrin of various structures, but same
overall concentration. Thus, for a small volume of clot AV
with length LAv of fibers (see Appendix) of average radius
Rf, the fiber surface concentration of a particular site avail-
able for reaction or adsorption is defined in Eq. 9 where qi
is the number of the ith site on each fibrin monomer and Na,
is the Avogadro constant. In general, qi can be a function of
the extent of local lysis if binding sites are revealed in nicked
fibrin. The sites may be filled, however, and are then un-
available for adsorption.
LAV 2 fibrin monomersOi, ,uM ith site = qi*{m(Rf)}* 45nAV 45 nm
1 (106,pmol/mol) 9
Nay (10 -3 L/cm3) (
In this approach, qi is 2.0 binding sites per monomer for
glu-plasminogen and plasmin binding (Suenson and
Thorsen, 1981; Bok and Mangel, 1985; Fears, 1989); 1.5
binding sites per monomer for tPA binding (Husain et al.,
1989; Higgins and Vehar, 1987), and 10 kinetically fa-
vored cleavage sites per monomer for plasmin degradation
of fibrin (Pizzo et al., 1973; Ranby and Brandstrom, 1988).
See Table 2.
Lysis of fibrin by plasmin
Very little intrinsic kinetic data are available for the mo-
lecular level action of plasmin on three dimensional networks
of fibrin. Most experiments using 1251I-fibrin release yield
overall solubilization rates without recovery of fundamental
rate constants due to the large distribution of cleavage sites
and degradation products generated during lysis (Pizzo et al.
1973; Ranby and Brandstrom, 1988). Ample data exists for
the cleavage of small soluble substrates such as H-D-val-
leu-lys-p-nitroanilide (S-2251) (Robbins et al., 1981), H-D-
pro-phe-arg-pNA (S-2302), H-D-val-leu-arg-pNA (S-2266),
tosyl-gly-pro-lys-pNA (chromozym-PL), (Lottenberg et al.,
1981), and tosyl-arg-methyl ester (TAME) (Robbins et al.,
1965). During fibrinolysis, however, very complex kinetic
phenomena arise when the insoluble fibrin network is de-
graded by plasmin. Lysine binding sites for plasmin, plas-
TABLE 2 Summary of kinetic parameters for the activation
of plasminogen and the degradation of fibrin
(b = bound, f = free)
Irreversible reaction Kinetic constants* Reference
p1gb + tPAb p1mb glu-plasminogen Hoylaerts et al.
k2 = 0.10 s-' (1982)
Km = 0.16 ,uM
lys-plasminogen
k2 = 0.2 s-'
Km = 0.02 ,uM
plgf + uPA plmf glu-plasminogen Lijnen et al. (1989)
k2 = 3.6 s-1
Km = 78 ,uM
lys-plasminogen
k2 = 4.6 s-1
Km = 3.8 ,uM
fbn + p1mb FDP glu or lys-plasmin Lottenberg et al.
k2 = 25 s-1 (1981)t
Km = 250 ,uM
Values represent nominal activation rates obtained for plasminogen ac-
tivation by single or two-chain tPA in the presence of unnicked or nicked
fibrin. Similarly, nominal rates are given for plasminogen activation by
recombinant two-chain urokinase.
* The average kinetic parameters for cleavage of fibrin by plasmin are es-
timated from synthetic substrates. Parameters are for Eq. 12.
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minogen, and tPA are revealed on the C-terminal lysine of
cleaved chains of the nicked fibrin (Harpel et al., 1985; de
Vreis et al., 1989). Plasmin adsorbs reversibly to fibrin with
an association with fibrin which is stronger than glu-
plasminogen to fibrin and similar or stronger than lYS77-
plasminogen binding to fibrin which binds with a Kd = 0.2
to 10 p,M (Suenson and Thorsen, 1981; Bok and Mangel,
1985). The binding of active site-inhibited glu-plasmin to
purified fibrin has been evaluated to have a Kd of 0.5 ,uM
(Suenson and Thorsen, 1981). Once bound, plasmin pro-
ceeds to engage in its active site the cleavage sites. Addi-
tionally, plasmin may immediately form the activated
enzyme-substrate complex as plasmin moves from the so-
lution phase onto the fibrin. In this sense, the active site of
plasmin may be considered to facilitate plasmin binding to
fibrin. Once bound to fibrin, plasmin can desorb but tends to
remain localized to the fibrin phase since it is protected from
a2-antiplasmin inhibition.
We have assumed that fibrin bound plasmin reversibly
engages its potential cleavage site. Thus, the kinetic descrip-
tion for the rate of fibrin cutting would follow a Michaelis-
Menton description. The reaction velocity should go to zero
as the fibrin becomes fully degraded (no cleavage sites or
bound plasmin available) and reach a maximum rate in the
presence of excess fibrin sites. We have assumed that plas-
min cleaves all the potential cut sites of the fibrin monomers
at an average rate as shown in Eq. 10.
By evaluation of the instantaneous rate of cutting
{(x' ,pt' M/s} at some location x' at some time t', it is
possible to calculate the historic amount of cutting {{(x', t'),
,uM of cuts made at x' and t'}. By defining a solubilization
factor y, which relates the number of fibrin monomers solu-
bilized to the number of cuts made, the amount of solubi-
lization or lysis {L(x', t'), ,uM of fibrin lyzed at x' and t'}
can be defined as a function of the historic amount of cuts
made by plasmin at position x'. The solubilization factor has
been estimated to be a constant with a value of 0.1. This
corresponds to the estimate that for every 10 cleavages by
plasmin, an equivalent of one subunit of fibrin is solubilized
(Ranby and Brandstrom, 1988). This approach does not ac-
count for any dependence of plasminogen activating activity
or plasmin activity on the actual radius of the fiber which is
known to exist with very thin fibrils (Gabriel et al., 1992).
.*?(x', t') = k2cb (XI, t') O=pll(x', t') (10)Km + Oplm(x', t')
rt,O(Xf, t') = XJ Ix' t) dt (11)
L(x', t') = Oy x', t') (12)
The % lysis is defined as
% lysis = L(x', t')/(Cfbn). at x', t' (13)
and the time-evolving fiber radius which decreases with lysis
is given as
(14)
r L(x', t') 1/2
S( LT A 2 monomers 1 (106' pmol/mol)
L VOlT) 45 nm Nv (10-I I/cm3) J
The advantage of this approach is the relation of kinetic rates
and stoichiometry to the time-evolving gel structure at the
molecular level. We have used one phenomenological pa-
rameter y to capture the poorly defined process of release of
partially degraded fragments. Although the actual fiber is
quite porous with a void fraction of 0.8, binding interaction
of penetrating proteins with the protofibrils may likely lo-
calize these proteins to the outer domains of the fiber. Our
approach does not distinguish between species trapped inside
fibers during clotting or species bound to the surface of fi-
bers, but does specify that all lysis occurs on the fiber surface
(Fig. 1). It is likely that both surface and inner fiber lysis
(Carr and Hermans, 1978; Carr et al., 1992) occur in reality
but the relative contributions are not known.
The kinetic parameters for plasminogen activation by
bound tPA, solution phase activation of plasminogen by uro-
kinase, and plasmin degradation of fibrin by plasmin are
given in Table 2. Given the already complex nature of con-
vection and reaction with a multicomponent heterogeneous
system, some simplifications were required prior to explor-
ing more complex systems. We have neglected fluid-phase
activation of plasminogen by tPA which is kinetically
slow. The inhibitory effects of a2-antiplasmin and PAI-1
either in solution or on fibrin were not considered. We also
have not considered the conversion of single-chain tPA to
two-chain tPA or the conversion of prourokinase (single
chain-uPA) to two-chain-uPA (urokinase). Additionally,
we have not considered the conversion of glu-plasminogen
to Iys77-plasminogen or the generation of glu-plasmin or
Iys77-plasmin, although the simulation can use parameters
for either glu or lys-plasminogen. We have not considered
the generation of binding sites in partially degraded fibrin
as lysis proceeds or the modulatory action of fibrin degra-
dation products on enzyme activities. We have neglected
the biochemical role of various proteins such as albumin,
collagen, fibronectin, heparin, and lipoprotein. Finally,
these simulations have focused only on the biochemistry of
the major proteins of fibrinolysis without consideration of
the many cellular contributions of red blood cells, platelets
(Miles and Plow, 1985), neutrophils, or the invading fibro-
blasts of older clots.
A multicomponent convection/dispersion model
of fibrinolysis with heterogeneous adsorption
and reaction
Fibrinolytic therapy is intrinsically transient. The time-
dependent and space-dependent concentration of various
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FIGURE 2 Summary of the fibrinolytic reaction pathway and compo-
nents considered in the model. Plasminogen is activated to plasmin in the
solution phase by urokinase while solid phase plasminogen activation re-
quires tPA to be bound to the fibrin. Not included in the present study is
the inhibition of soluble plasmin and tPA by a2-antiplasmin or PAI-1, re-
spectively. Diffusion and convection of soluble species can occur in the fluid
phase. Soluble species can reversibly adsorb and desorb to the fibrin phase.
Plasminogen and plasmin compete for the same sites on the fibrin monomer.
Each site can bind only one molecule at a time. All kinetic constants are
given in Table 1 for reversible adsorption and Table 2 for irreversible en-
zymatic reaction.
species in the fluid and fibrin phase are described by gov-
erning Eqs. 15a-d and 16a-d, respectively, and Danckwerts
boundary conditions for convection-dominated transport at
the clot boundaries (Eq. 17a-b) and initial conditions (Eq. 18)
for one-dimensional convective/dispersive transport. The
binding of urokinase to fibrin was neglected. The reaction
network is summarized in Fig. 2. Plasminogen and plasmin
compete for the same site on each fibrin monomer while tPA
binds its own unique site (Eq. 16a-b). Plasminogen must be
bound to fibrin in order to be activated by bound tPA (Wu
et al., 1990). Since all the soluble species have a molecular
weight between 50 and 80 kDa, we have used a Brownian
diffusion coefficient of 5 X 10-7 cm2/s for all the soluble
species (Tyn and Gusek, 1990; Park et al., 1988). The Brow-
nian contribution in the calculation of the longitudinal dis-
persion coefficient is quite small for Peclet number much
greater than 1. Also, we have neglected in Eq. 15b-c the small
amount of urokinase and plasminogen bound temporarily to
each other during catalysis.
Numerical solution method
The set of transport equations was solved numerically using
a weighted-average finite difference method (Crank-
Nicholson method, weight factor = 0.5) with space deriva-
tives averaged over two successive dimensionless time steps
of 10-6 (t * L2/DL) (Gupta and Greenkorn, 1973). The spatial
domain (1-cm clot length) was discretized with only 11 nodes
to provide numerical stability for the multicomponent sys-
tem. The system was solved on a SUN4 (SUNOS 4.1.2) and
required under 5 min of CPU per run. The solution was nu-
merically stable for an initial Peclet number up to about 500.
At the start of each run the following parameters were set:
initial concentrations, inlet conditions, initial permeation ve-
locity, initial fiber radius. At each time step, the concentra-
tion profiles and the local historic amount of lysis L(x', t')
were evaluated. Then, the local percentage lysis (Eq. 13),
fiber radius (Eq. 14) and porosity were evaluated in order to
update the local specific permeability k(x', t') by Eq. 2. The
overall permeation velocity at constant pressure drop across
the clot was evaluated using the clot-averaged specific per-
meability. With the updated superficial velocity, new con-
centrations profiles were evaluated at the next time step.
Simulations were stopped as the overall lysis of the clot ap-
proached 80% since increasing velocities led to high Pe and
associated oscillations in the solution. Adaptive mesh algo-
rithms were not necessary to achieve stable solutions for the
Peclet numbers used in the present work. Using refined
meshes (25 or 45 nodes) led to longer run times with little
gain in numerical stability, but also gave slightly sharper
fronts. Thus, with the 11 node mesh, numerical dispersion led
to a small over estimation (<15%) of species penetration
ahead of the front.
Fluid phase (f = free, b = bound)
aCfPA a2cf aCfAtA tA - ID~tP PA _ tPAx
-(1- e)acdtPA
ac, ~a2cf acf
uPA uPA DuPA uPA uPA
at L ax2 ax
pg acfj a2cf1 acf1Ig
at -L ax2 e a
E )acr b uPA f fc~s
E at VKuPA +cfl
plm D""c 02cfm acf
at L ax2 ax
knoa)
(15b)
(15c)
(15d)
/1 - E aCaPIm (kuPAcpAcg
E Jat KumPA + cf
Solid fibrin phase
aCb
tPA tPA = ktPAcf(0 CbA) k PAcbA
at ftPA(otPA -P P
ac pjs = kP'9cf go -C - cplg Kgat p g(OpIgIm - CpIg - CPim)
ktPACb CbAkplgCb (kA PACplg_
Pig KtPA + Cb/
m pig
(16a)
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TABLE 3 Physical and biochemical parameters for fibrin clots
Fibrin Structure and Transport Properties
Fibrin monomer size
Rf, radius of fibrin fiber formed at high ionic strength (0.3M)
Rf, Radius of fibrin fiber formed at low ionic strength (0.1M)
DPore, diameter of pore
Overall fibrin porosity, E = Vvoid/Vt.t.I
Specific permeability
Peclet number number, Pe = v - L/DL
AP/L
Arterial
Venous
Biochemical constituents
tPA
uPA
PAI-1
a2-antiplasmin
Plasminogen
Plasmin
Fibrinogen
Fibrin monomer (in clot)
MW (kda)
72
54
55
67
88 (glu-plg)
83 (lys-plg)
88 (glu-plm)
83 (lys-plm)
340
45 nm X 6 nm
4 to 50 nm (fine gel)
200 to 500 nm (coarse gel)
0.1 (fine) to 10 gm (coarse)
>0.99 (plasma gel)
0.9 - 0.99 (platelet-retracted clots)
0.75 - 0.9 (flow-compacted fibrin)
10-8 CM2 (coarse) to 10-12 cm2 (fine)
0 to &(103)
-60 mm-Hg per cm-clot
0 to 10 mm-Hg per cm-clot
[conc]plasma
0.1 nM
0.1 nM
0.2 nM
1.0 ,uM
2.2 ,iM
1/2 - 0.1
8.8 ,uM
[conclclot*
<5%
-20%
-5-25%
-50-70%
T1n - 102 to 103
8.8 ,iM (plasma clot)
88 ,uM (platelet retracted)
220 ,uM (flow-compacted)
* Fibrin bound concentration as percentage of plasma concentration, or half-life (T1/2) for short-lived species, or ,uM. During clotting, soluble proteins can
also be crosslinked by factor XIIIa such that bound concentrations approach the plasma concentration. These values are consistent with typical values for
equilibrium binding to preformed plasma clots or purified fibrin clots.
plm ca = kfPlmIplm(pg/m PClg - cPlm)
- kplmC b + (Ak2ACpAgl
r pim KtPA + cpb/ (16c)
Boundary conditions (for free species)
ac.Inlet: vCiinlet = vc D - (17a)
for i = tPA, uPA, plg, plm, where
Jci = ° for t<0 and t > t*
Ci,inlet(t) Ci = Ci bolus for 0 < t < t*
ac.
Outlet:
ax
= 0 at x = Lclot (t> 0) (17b)
for i = tPA, uPA, plg, plm
Initial conditions (for bound and free species)
cj(x, t = 0) = ci0for O < x < Lclt (18)
for = tPA, uPA, pig, pim
RESULTS
For each simulation, the following initial conditions were
specified (see Table 3): bulk fibrin concentration, initial fiber
radius, initial free and bound plasminogen concentration (in
equilibrium with fibrin), and plasminogen subtype used (glu
or lys). By setting the pressure drop constant and the con-
centrations and duration of the bolus perfusion, the problem
was specified for each simulation. In certain simulations to
illustrate particular phenomena, reaction rates were set to
zero or other modifications were made as described.
Penetration and partitioning of proteins in
preformed fibrin
To explore the dynamic partitioning of individual species to
fibrin under conditions of permeation, the irreversible reac-
tions (Table 2) were all set to zero, corresponding to active-
site inhibition. A 0.5-min bolus (finite step input) of 1 ,uM
of tPA, glu-plasminogen, and uPA was administered to a
flow-compacted fibrin clot at constant APIL = 50 mm-
Hg/cm (Pe = 421). After 0.5 min, the inlet concentrations
were set to zero. Concentration profiles after 30 min of per-
meation are shown in Fig. 3 for the free and bound concen-
trations of the penetrating species. Urokinase moved with the
permeation front which was located at 0.378 cm after 30 min.
The uPA moved ahead of the free tPA and free plasminogen
since it had no binding interaction with the fibrin. The mo-
bility of tPA and plasminogen was reduced because of fibrin
adsorption. Each component became highly dispersed under
these permeation conditions with a small amount of each
species moving ahead of the permeation front. The tPA rap-
idly bound the fibrin of the clot (Fig. 3 B), and after 30 min
a majority of the tPA was bound to fibrin. For tPA parti-
tioning, a non local equilibrium state occurred-a significant
2629Diamond and Anand
Volume 65 December 1993
A
-
x
._
1z
q
0
.0.
I-co
C"
g-
as
:i
FIGURE 3 The penetration and partitioning of
tPA, uPA, and glu-plasminogen (glu-plg) into a
coarse (Rf. = 250 nm), compacted (220 ,uM fi-
brin) clot after 30 min with fluid permeation
driven by a constant pressure drop of 50 mm-
Hg/cm (Pe = 421). All plasminogen activation
and fibrin degradation reaction rates were set to
zero, thus no plasmin was generated and the fibrin
properties remained constant during the simula-
tion. Inlet concentrations for the 0.5 min bolus
were set to 1 ,uM for each species. (A) Free phase
concentrations. (B) Bound concentrations.
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amount of bound tPA at the inlet (x = 0) coexisted with a
zero free phase tPA concentration. Local equilibrium would
dictate that the concentration of tPA on the fibrin be zero if
the solution phase concentration of tPA were zero. Bound
glu-plasminogen desorbed from fibrin more rapidly than
tPA, and conditions of local equilibrium were more closely
approached for the partitioning of glu-plasminogen to fibrin
under permeation conditions. In other simulations, the trans-
port of lys-plasminogen and active-site inhibited plasmin oc-
cuffed under non local equilibrium conditions due to strong
fibrin binding.
Plasminogen activation by tPA and lysis under
conditions of permeation
When using tPA as a lytic agent, many factors ultimately
control fibrin lysis. A typical arterial thrombi would expe-
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
X (cm)
rience a pressure drop across the clot of about 50 mm-Hg/
cm-clot. Under this flow condition, a 5-min bolus of 1 ,uM
tPA caused a sharp lysis front to move across a coarse, com-
pacted clot which had been preequilibrated with glu-
plasminogen (Fig. 4). Over 80% of the clot was predicted to
be lyzed by 45 min. At constant pressure drop, the perme-
ation velocity and the lysis front velocity increased as the clot
was lyzed. This is seen in Fig. 4 by comparing the lysis
profile at 15 min with the profile at 30 min. This acceleration
was due to the accumulation of plasmin with time and the
increase of overall clot permeability with lysis.
To demonstrate the fundamental impact of permeation on
overall fibrinolysis, simulations were run at different pres-
sure drops of 1, 10, and 50 mm-Hg/cm-clot (Fig. 5 A). For
lysis of a clot that contained no plasminogen prior to lytic
treatment (Fig. 5A-C), the APIL had a strong effect on lysis.
After 15 min of lysis at AP/L = 1 mm-Hg/cm, only the front
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FIGURE 4 Spatial distribution of tPA-mediated fibrinolysis under
convective-dispersive transport at various times. Simulations were for lysis
of a flow-compacted (220 ,uM fibrin), coarse (Rf. = 250 nm) clot which
was pre-equilibrated with 2.2 ,uM glu-plg (initially, cp, = 0.940 ,uM and
cf = 1.856 ,uM). The permeation was driven by AP/L = 50 mm-Hg/cm
(initial Pe = 421 and permeation velocity = 2.10 X 10-4 cm/s). Inlet con-
ditions were: 1.0 ,uM tPA, 0 ,uM uPA, 2.2 ,uM glu-plg, 0 ,uM plm for a bolus
(fmite step input) of 5 min, after which all concentrations were set to zero,
except for glu-plg, which was maintained at 2.2 ,uM.
0.1 cm of the clot was slightly lyzed (10%). This was in
contrast with nearly 0.2 cm of the clot being highly lyzed at
a APIL of 50 mm-Hg/cm-clot, corresponding to about a 20-
fold increase in fibrin solubilization at the higher pressure
drop. Although the higher flows led to delivery of more tPA
during the 5-minute bolus, similar results were found when
a constant mass of tPA was administered at various pressure
drops. Thus, the variation in tPA-mediated lysis profiles in
Fig. 5A was due to the enhancement of tPA penetration with
increasing pressure drop. The bound and free concentrations
of each species after 15 min of lysis for constant APIL = 50
mm-Hg/cm are shown in Fig. 5, B and C, respectively. Al-
most all of the plasmin generated on the fibrin by tPA re-
mained bound to the fibrin. Bound concentrations of plas-
minogen were quite low due to the rapid conversion to
plasmin by bound tPA. The bound concentrations of all spe-
cies at the inlet (x = 0 cm) were zero after 15 min due to
complete lysis of fibrin in this region of the clot.
Fibrinolysis with tPA was greatly enhanced when the clot
structure contained 2.2 p,M glu-plasminogen (equilibrated
with the fibrin) prior to the lytic therapy (Fig. 5, D-F) when
compared to lysis of a clot containing no plasminogen. Per-
meation had a large enhancing effect on the extent of lysis.
For a 5-min bolus of 1 ,uM tPA, over 0.2 cm of the clot was
fully lyzed after 15 min at APIL = 50 mm-Hg/cm. This is
in contrast to mild lysis of less than 0.1 cm of the gel at APIL
= 1 mm-Hg/cm. The concentration profiles for each species
after 15 min of lysis for APIL = 50 mm-Hg/cm are given in
Fig. 5,E and F. Release ofbound species from the fully lyzed
front of the clot accounts for the increase in the plasminogen
and tPA concentration in the free phase at x = 0.2 cm.
Continuous infusion of glu-plasminogen into the clot leads
to the concentration profile seen in Fig. 5 E. Ahead of the
lysis front at x = 0.3 cm, significant quantities of bound
tPA led to rapid local conversion of bound glu-
plasminogen to plasmin. For fibrinolysis in the absence of
the inhibition reactions (by PAI-1 or antiplasmin), the de-
livery by permeation of only a few micrograms of active
tPA for a few min into a clot was predicted to result in ki-
netically significant plasminogen activation and fibrinoly-
sis over the course of 15 min.
Plasminogen activation by uPA and lysis under
conditions of permeation
Similar to the above analysis, we have conducted simulations
of fibrinolysis using a 5-min bolus administration of 1 ,uM
urokinase (uPA). These simulations were run for a coarse
compacted clot containing no plasminogen prior to lysis (Fig.
6,A-C) or equilibrated with plasminogen (Fig. 6, D-F) prior
to lysis. Fibrinolysis mediated by uPA was greatly enhanced
by the presence of permeation driven by a pressure drop of
50 mm-Hg/cm (Fig. 6A) as compared to lysis under a AP/L
of 1 or 10 mm-Hg/cm. Since uPA had no ability to bind
fibrin, it was able to penetrate deeply into the clot at high
pressure drops. With high permeation rates of uPA into the
clot, the lysis rate was high in the interior of the clot as well
as at the front of the clot. In contrast to the simulations for
tPA, the plasmin generated by uPA reached relatively high
levels in the free phase (Fig. 6B). Even a highly lyzed region
(>80%) of the clot had significant capacity to bind plas-
minogen (Fig. 6 C). When the clot was equilibrated with
glu-plasminogen, lysis was particularly intense within the
clot interior at x = 0.1 cm where the urokinase had pen-
etrated so as to achieve full lysis within the clot but not at
the front of the clot (Fig. 6 D). In reality, this would lead
to a flow-induced collapse of the clot which we have not
modeled since the fibrin was defined as the non-mobile,
stationary phase. Where lysis reached 100% locally at x =
0.1 cm, the bound concentrations of the species went to
zero as expected (Fig. 6 F). At AP/L = 50 mm-Hg/cm, the
preexisting free plasminogen is rapidly activated locally
where the urokinase bolus has penetrated (Fig. 6 E) but
plasminogen was replenished behind the bolus with fresh
perfusate. The local depletion of plasminogen by urokinase
in the fluid phase led to reduced plasminogen binding to
the fibrin and enhanced plasmin adsorption to fibrin at this
position of the clot (Fig. 6 F).
Effects of fibrin fiber radius on lysis
The ionic strength during fibrinogen polymerization controls
the thickness of the fibrin fibers. The fibers may be very fine
with only a few protofibrils associated together or may be
very coarse with hundreds of fibrils in a fiber bundle. To
explore the effects of fiber radius on transport and kinetics,
we carried out simulations at constant Peclet number (Pe) or
constant AP/L for lysis of clots with the same bulk fibrin
concentration but with varying initial fiber radius Rf0 from
25 to 500 nm. The time to achieve 50% average lysis (T50)
was used as an index of the overall lytic efficiency.
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FIGURE 5 Fibrinolysis mediated by tPA of a coarse, compacted clot. Fibrin structure and inlet conditions were identical to those of Fig. 4. Penetration
of a lytic front after 15 min was greatly enhanced under conditions of increasing permeation at AP/L = 1, 10, and 50 mm-Hg/cm-clot for lysis of clots
that contained no glu-plasminogen before lysis (A). The free phase (B) and fibrin bound (C) concentration profiles for glu-plasminogen, plasmin, and
tPA are given for lysis after 15 min at a AP/L = 50 mm-Hg/cm-clot. Lysis after 15 min was greatly enhanced under conditions of increasing permeation
as seen at APIL = 1, 10, and 50 mm-Hg/cm-clot for lysis of clots that contained glu-plasminogen (cb,g = 0.940 ,LM and cf,g = 1.856 JIM) prior to the
lytic regime (D). The free phase (E) and fibrin bound (F) concentration profiles for glu-plasminogen, plasmin, and tPA are given for lysis after 15 min
at a AP/L = 50 mm-Hg/cm-clot.
In simulations at constant pressure drop, fine fibers caused
a reduction in specific permeability, while coarse fibers led
to enhanced permeation and subsequently enhanced lysis
rates and reduced T50 (Fig. 7, A and C). For plasma clots
(8.823 ,uM fibrin), a very slight minimum was seen in the T50
for very coarse fibers undergoing lysis at a constant APIL =
0.01 mm-Hg/cm (Fig. 7 A). This was due to the competing
effects of reduced permeation and enhanced available site
concentration in fine clots; coarse clots had high specific
permeability, but reduced available site concentrations (Eq.
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FIGURE 6 Fibrinolysis mediated by urokinase (uPA) of a coarse, compacted clot. Fibrin structure and inlet conditions were identical to those of Fig. 4
except that uPA was used instead of tPA as the lytic agent. Lysis after 15 min was greatly enhanced under conditions of increasing permeation as seen at
AP/L = 1, 10, and 50 mm-Hg/cm-clot for lysis of clots that contained no glu-plasminogen before lysis (A). The free phase (B) and fibrin bound (C)
concentration profiles for glu-plasminogen, plasmin, and uPA are given for lysis after 15 min at a AP/L = 50 mm-Hg/cm-clot. Lysis after 15 min was greatly
enhanced under conditions of increasing permeation as seen at AP/L = 1, 10, and 50 mm-Hg/cm-clot for lysis of clots that contained glu-plasminogen
(Cblg = 0.940 ,uM and cf = 1.856 ,uM) before lysis (D). The free phase (E) and fibrin bound (F) concentration profiles for glu-plasminogen, plasmin,
and uPA are given for lysis after 15 min at a APIL = 50 mm-Hg/cm-clot.
6 and 9). At constant APIL greater than about 0.02 mm- lysed. With compacted clots, coarse fibers led to a greater
Hg/cm across plasma clots subjected to a 5-min bolus of permeability such that 50% overall lysis was achieve within
either 1 ,uM tPA or uPA, no minimum in the T50 profile was about 20 min for a bolus of 1 ,uM of either uPA or tPA (Fig.
seen since the permeability effects became more pronounced 7 C). Compacted clots with fine fibers had very low specific
and controlled the lysis rates. In general, at AP/L greater than permeability and required in excess of 100 min to achieve
0.02 mm-Hg/cm, the coarser the plasma clot, the faster it 50% average lysis.
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FIGURE 7 Effect of initial fiber radius (Rf0) on the time to achieve 50% average lysis (T5o). Simulations for lysis of plasma clots (8.8 ,M fibrin) (A,
B) or compacted clots (220 ,uM fibrin) (C, D) were run at a constant pressure drop of 0.01 mm-Hg/cm (A) or 50 mm-Hg/cm (C) or at constant permeation
velocity (constant Pe = 421) (B, D). An inlet condition was set for a 5-min bolus of either 1 ,uM tPA (0) or uPA (@) with continuous introduction of 2.2
,uM glu-plasminogen at the inlet. In all cases, fibrin was equilibrated with 2.2 ,uM glu-plasminogen (cbpig = 0.940 ,iM and cfplg = 1.856 ,uM) prior to lysis.
Simulations run at constant Pe = 421 (i.e., constant
velocity) correct for the fact that gels with fine fibers have
a lower specific permeability than gels at the same bulk
fibrin density with thick fibers. The pressure drop across
the clot was adjusted in order to maintain constant Pe. For
plasma clots, the pressure drop was adjusted from 5.25
mm-Hg/cm (Rfo = 25 nm) to 0.013 mm-Hg/cm (Rfo =
500 nm) to maintain constant Pe (Fig. 7 B). For compacted
clots, the pressure drop was adjusted from 5000 mm-
Hg/cm (Rf. = 25 nm) to 12.5 mm-Hg/cm (Rfo = 500 nm)
to maintain constant Pe (Fig. 7 D). Although simulations
at constant velocity are feasible numerically, experiments
run under these conditions (such as AP/L = 5000 mm-Hg/
cm) will cause flow-induced compaction of the lysing
fibrin-a front sharpening effect with large dynamic
changes in fibrin density. The model, which treats the
fibrin as an immobile network, can not account for such
effects.
In Fig. 7 B, a 5-min bolus of 1.0 ,uM uPA or tPA (at
perfusion velocity) lyzed fine plasma clots faster than coarse
clots. This is expected stoichiometrically since more fibrin
monomers are hidden inside the thick fibers while thin fibers
have exposed on their outer surface more of the fibrin mono-
mers. Reduction of accessible monomers leads to a reduction
of available binding and reaction sites (Eq. 6 and 9). A 20-
fold increase of fiber radius (25 nm to 500 nm) caused a
prolongation by about 5-fold of the T50 of very coarse plasma
gels compared to very fine plasma gels. With a lytic regime
of a 5-min bolus of 1 ,M tPA or uPA and constant Pe = 421,
the T50 of compacted clots (220 ,uM fibrin) was only slightly
less for fine clots than for coarse clots (Fig. 7D). In the dense
compacted clots, a 20-fold increase of fiber radius caused
only a modest 1.8-fold increase of T50. This was due to the
fact that in dense clots, the available concentration ofbinding
and reaction sites of the fibrin were in great excess and were
not strongly limiting relative to the concentrations of plas-
minogen, tPA, or uPA.
Observations of fine gels (formed in angiographic contrast
fluid) being resistant to lytic agents (Carr and Hardin, 1987;
Nair et al., 1991; Gabriel et al., 1992) are thus likely due to
intrinsic changes in enzyme kinetic constants or adsorption
rate constants, and are less likely to be mediated by transport
100(
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processes. In vivo, fine clots may be resistant to lytic therapy
by two mechanisms: alteration of intrinsic adsorption or re-
action kinetics and poor inner clot permeation.
Relaxation of steric hindrance constraint for
binding and reaction
In calculating the binding site concentrations on the surface
of the fibrin fibers we have assumed that only the protofibrils
on the outer surface of the fiber were sterically accessible for
adsorption or reaction. Relaxation of this steric hindrance
constraint can be achieved simply by including some inner
"shells" of protofibrils in addition to the outer shell of pro-
tofibrils (see Appendix). The number n of protofibril "shells"
available for reaction is related to a multiplying factor K by
n = (K + 1)/2. For K = 1, only the outer "shell" ofprotofibrils
A 100
U,
0
If,
FIGURE 8 Effect of relaxation of steric hin-
drance constraint on the time to achieve 50% av-
erage lysis (T50). Coarse plasma clots (Rf. = 250
nm; 8.8 ,uM fibrin) (A) or coarse, compacted clots
(Rf. = 250 nm, 220 puM fibrin) (B) were subjected
to a lytic regime of 1 ,uM uPA (0) or tPA (0) for
5 min with continuous infusion of 2.2 ,uM glu-
plasminogen. The pressure drop was 0.052 (A) and
50 mm-Hg/cm (B) such that the initial Peclet num-
ber was 421 in all cases. The parameter K is defined
in the text and Appendix as an index of the number
of protofibril "shells" of the fibrin fiber which can
participate in adsorption and reaction during fibri-
nolysis (See insert). The number of shells n is de-
fined as (K + 1)/2. For K = 1 only the outer shell
of fibrils participate in adsorption and reaction,
while for K = 100 nearly all the fibrils in the fiber
were available for adsorption or reaction.
B
of the fiber participated in reactions, while for K = Rf/ro all
the monomers in the protofibrils of the fiber were available.
Setting K = Rf/r. is equivalent to having the bulk concen-
tration of fibrin available for all reaction and adsorption pro-
cesses. By increasing the volume-averaged site concentra-
tion Oi with increasing K, the adsorption rates of tPA,
plasminogen, and plasmin are enhanced with subsequent en-
hancement of plasminogen activation, plasmin binding, and
fibrin degradation. Relaxation of the steric hindrance con-
straint to allow for protofibrils within the deeper interior of
the fiber to participate in reactions led to an expected kinetic
enhancement of the lysis rate (Fig. 8). In clots of low fibrin
concentration (8.823 ,uM), the sites for adsorption and re-
action are limiting (relative to the concentration of the 5 min
bolus) and fibrinolysis was enhanced by including more pro-
tofibrils of the fiber with increasing K (Fig. 8 A). Inclusion
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K ,n shells = (ic + 1)/2
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E
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K ,n shells = (ic + 1)/2
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of just two outer "shells" of protofibrils of the fiber (K = 3)
led to a sufficiently high site concentration in compacted
clots such that plasminogen activation and plasmin activity
were not limited by the number of fibrin sites. In these dense
clots, increasing K greater than 1 had little effect on T50 sug-
gesting that the steric hindrance constraint is not a significant
limitation for lysis of these clots. During fibrinolysis of real
fibrin, the fibers may swell or fray as lysis proceeds such that
more protofibrils participate in the reactions (equivalent to K
increasing). Such a phenomena would likely depend on the
extent of crosslinking. From Fig. 8, it appears that the en-
hancement in lytic rates due to this swelling of the fibers
would be relatively minor for dense clots but several fold for
plasma clots.
Comparison of Glu versus Lys plasminogen
Although we have not considered the enzymatic conversion
of glu-plasminogen to lys-plasminogen or the generation of
lys-plasmin, it was possible to run the model using binding
and reaction constants for lys-plasminogen (Tables 1 and 2).
Lys-plasminogen is activated more rapidly than glu-
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-
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plasminogen by either uPA or tPA. Additionally, lys-
plasminogen binds fibrin with much greater avidity than glu-
plasminogen. Simulations of lysis demonstrated that lys-
plasminogen was much more effective than glu-plasminogen
in facilitating fibrinolysis of either plasma clots or flow-
compacted clots (Fig. 9). Under the conditions tested, the
reduced mobility and strong fibrin partitioning of lys-
plasminogen did not significantly reduce its capacity to be
activated by urokinase. In contrast, the stronger avidity be-
tween uPA and free phase lys-plasminogen led to rapid ac-
tivation to form lys-plasmin. Although lys-plasminogen led
to more rapid lysis when compared to glu-plasminogen under
conditions of flow, the extent of this enhancement was de-
pendent on the initial conditions and time of simulation. Lys-
plasmin may have some advantage in that it is more rapidly
formed on fibrin by tPA, thus protecting it from antiplasmin
inhibition.
How important is permeation?
Permeation of fibrinolytic mediators through the interstitial
regions of a blood clot is expected if a pressure drop exists
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FIGURE 9 Effect of glu-plasminogen and lys-plasminogen on the spatial distribution of lysis after various times. Lysis profiles are given after 5 min
(circles) and 15 min (squares) for lysis with glu-plasminogen (solid symbol) or lys-plasminogen (open symbol). Simulations were for the lysis at APIL
= 0.052 mm-Hg/cm of a coarse, plasma clot subjected to a 5-min bolus of 1 ,uM tPA (A) or uPA (B) or for the lysis at AP/L = 50 mm-Hg/cm of a coarse,
compacted clot subjected to a 5-min bolus of 1 ,uM tPA (C) or uPA (D). In all simulations, the clots were prelaid and equilibrated with 2.2 ,uM of the
plasminogen subtype indicated.
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across the clot. Although no measurement of this intersti-
tial fluid velocity within real blood clots has ever been
made, the ability to reperfuse an arterial thrombi within an
hour after initiation of thrombolytic therapy strongly sug-
gests that diffusion is not the sole mode of transport. To
demonstrate the very strong impact of permeation pro-
cesses on thrombolytic therapy, we have run simulations
over a wide range of transport regimes ranging from diffu-
sion dominated (Pe < 1) to convection dominated (Pe > 1).
The transition between these regimes is seen for lysis of
plasma clots (Fig. 10 A) and flow-compacted clots (Fig. 10
B). Without permeation, a coarse compacted clot exposed
to 1 ,uM tPA for 5 min will require over 1000 min to
achieve 50% lysis. With fluid permeation, this same lytic
regime of 5-min bolus of 1 ,uM tPA required under 20
min. Moving from a strongly diffusion-controlled regime
A 10000
FIGURE 10 The effect of pressure drop on the
time to achieve 50% average lysis (T50) for lysis of
coarse plasma clots (A) or coarse compacted clots
(B). The lytic regime was a 5-min bolus of either 1
,uM uPA (0) or tPA (0) with continuous infusion of
2.2 ,uM glu-plasminogen.
B
U,
0
.-O
to a strongly convection-controlled regime leads to an 98%
reduction in T50. In our own measurements of lysis fronts
moving across fine fibrin gels (8.8 ,uM fibrin) (S. Dia-
mond and J.H. Wu, unpublished observation), we have ob-
served about a 10-fold increase of lysis with the addition
of a pressure drop of 3.5 mm-Hg/cm-clot to push a 1 ,uM
plasmin solution through the gel (see Discussion).
Role of administration regime on lysis
We have calculated the effect of using tPA and/or uPA at
various concentrations under bolus and continuous admin-
istration regimes. Clinically, thrombolytic therapy is initiated
with a bolus dose followed by a low level infusion (Physi-
cians' Desk Reference, 1992). These administration regimes
can be simulated by changing the inlet concentration of each
0 .0001 .001 .01 .
AP/L (mm-Hg/cm)
.01 .1 1 10
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Diamond and Anand 2637
Volume 65 December 1993
species (Eq. 17a) to accommodate multiple bolus or other
infusion strategies. In Table 4, the time needed to achieve
50% average lysis (T50) is given as an index of the efficiency
of the administration regime.
In Table 4, the delivery of 1 ,uM tPA for 5 min (4.5 ,ug
tPA delivered into the clot) was sufficient to lyze half the clot
within 23 min. Doses of tPA sustained for 10 and 20 min or
higher concentrations of tPA (5 ,M) reduced T50 only
slightly compared to the 5 min bolus of 1 ,M tPA. Similarly
for uPA, increases beyond a 5 minute bolus of 1 p,M uPA
provided for only minor reductions of the T50. Under per-
meation conditions, even very low levels (0.1 FM) of uPA
or tPA provided for kinetically significant lysis. This oc-
curred since inhibition of tPA, uPA, or plasmin was not con-
sidered. Delivery of plasmin directly into a clot structure
however was not a particularly efficient lytic approach com-
pared to the equivalent delivery of uPA or tPA. Plasmin was
predicted to penetrate poorly through the clot due to its strong
binding. Also, plasmin can not continually activate plas-
minogen within the clot. No large advantage was gained us-
ing multiple bolus infusions or a bolus followed by con-
tinuous infusion; however, these results are influenced by the
absence of the inhibition reactions which would serve to
consume tPA or uPA. In general, under permeation condi-
tions in the absence of inhibition reactions, the first plas-
minogen activator to reach the clot in the first minutes will
contribute the most to the overall lysis. Subsequent amounts
of lytic agent which penetrate the clot at later times have a
lesser impact on the overall fibrinolysis.
Designing thrombolytic agents
With a numerical model of fibrinolysis, it was possible to
evaluate the outcomes which may occur by creating a new
fibrinolytic mediator using protein engineering. Several chi-
meric molecules have been developed and new wildtype
plasminogen activators are occasionally discovered (for ex-
ample, bat-tPA). By numerically modulating the fibrin af-
finity or reaction kinetics of a fibrinolytic mediator and
evaluating the therapeutic advantage, some guidelines for
protein engineering may emerge. Although the specific per-
meability of a clot controls lysis to a large extent, gains are
possible through protein engineering a plasminogen activator
or fibrinolytic mediator. These simulations do not take into
account the role of the inhibition reactions.
By numerically adjusting the adsorption rate constant (kf)
for tPA to fibrin while keeping the desorption rate constant
(kr) fixed, it was possible to evaluate the effects of changing
the Kd of tPA for fibrin. Increasing the Kd of tPA for fibrin
by reducing the kf from the wildtype value of 1.148 X 10-4
puM-1 s-' to 5 X 10-8 pkM-1 s-1 resulted in a strong reduction
in lytic efficacy. This change in kf led to a prolongation of
the T5o from 25 min to nearly 1000 min for a 5-min bolus
of tPA (1 ,uM) administered (AP/L = 50 mm-Hg/cm) to a
coarse, compacted clot prelaid with plasminogen. Interest-
ingly, reducing the Kd of tPA for fibrin by increasing the kf
in a reduction in lytic efficacy by a factor of two as indicated
in a prolongation of the T50. It was also possible to modulate
the Kd of tPA for fibrin by adjusting the desorption rate con-
stant kr while keeping kf fixed. Using this approach, there was
no change in T50 as a result of reducing the Kd from its
wildtype value of 0.58 ,uM to 0.1 nM for lysis of a coarse
compacted clots prelaid with plasminogen. Increasing the Kd
oftPA for fibrin from 0.58 ,uM to 100 ,uM caused only a 15%
prolongation of the T50.
This type of analysis would suggest that the efficacy of
tPA under flow conditions is nearly optimal for wildtype tPA
or recombinant tPA value ofKd = 0.5 ,uM. By increasing the
Kd slightly, tPA can penetrate into a clot structure somewhat
more easily, however, this advantage in clot penetration is
offset by poor activation of fibrin bound plasminogen. In-
terestingly, there was a disadvantage in reducing the Kd of
tPA for fibrin into the nM range by increasing kf. Under flow
conditions, increasing the forward adsorption rate constant
reduces the ability of tPA to penetrate into the clot with
consequent reduction in lytic efficiency. In general, when
tPA comes off the fibrin faster than bound plasminogen, the
kinetic rate of lysis is reduced.
By numerically increasing the adsorption rate constant kf
of plasminogen to fibrin from the wildtype value of 1.087 X
10-4 liM-1 s-' to 10'1 gM-1 s- provided no advantage in
lytic efficiency (as indicated by the T50) for lysis of coarse
compacted clots with tPA under flow conditions. This is ex-
pected since tPA and plasminogen adsorb at roughly the
same rates. However reducing the adsorption rate constant kf
of plasminogen to fibrin from the wildtype value of 1.087 X
10-4 ,gM- s-1 to 10-9 liM-1 s-' led to a 6-fold increase in
the T50. This indicated that sufficiently rapid adsorption of
plasminogen to fibrin was a critical step for tPA-mediated
plasminogen activation to proceed in a kinetically efficient
manner. It was also possible to modulate the Kd of plas-
minogen for fibrin by adjusting the desorption rate constant
kr while keeping kf fixed. Using this approach, there was no
change in T50 as a result of reducing the Kd from its wildtype
value of 38 ,M to 0.1 nM for lysis of a coarse compacted
clots prelaid with plasminogen. Increasing the Kd from 38
,uM to 1000 ,uM caused only a modest 30% prolongation of
the T50.
It was found that increasing the Kd of plasmin to fibrin
by increasing the rate of desorption (keeping kf fixed) led
to a decrease in the rate of lysis and a consequent increase
in the time required to achieve T50. Increasing the Kd from
the nM range to 100 ,uM served to prolong T50 by a factor
of about 1.5 for both tPA and uPA-mediated lysis. The rate
of lysis has been modeled to depend on the bound plasmin
concentration and therfore it is reasonable to expect that
increasing the rate of desorption reduces the amount of fi-
brin solubilized.
When the Kd of plasmin was altered by keeping the rate
of desorption constant and increasing the rate of adsorption,
no effect was observed for tPA-mediated lysis. However, it
was found that for uPA-mediated lysis, increasing the rate of
from 1.148 X 10-4 ,uM-1 s-1 to 10-1 ptM-1 s-5 also resulted
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TABLE 4 Comparison of administration regimes
Time to achieve 50%
Infusion scheme overall lysis (min)
Bolus delivery
5 min B (0.1 ,uM tPA)
5 min B (1.0 ,uM tPA)
5 min B (5 ,uM tPA)
10 min B (1.0 ,uM tPA)
20 min B (1.0 ,uM tPA)
5 min B (0.1 p.M uPA)
S min B (1.0 ALM uPA)
5 min B (5.0 ,uM uPA)
10 min B (1.0 ,uM uPA)
20 min B (1.0 ,uM uPA)
5 min B (0.1 ,uM plm)
5 min B (1.0 p.M plm)
5 min B (2.2 ,uM plm)
E (1.0 ,uM tPA; T1/2 = 5 min)
E (1.0 ,uM uPA; T1/2 = 5 min)
E (1.0 ,uM tPA; T1/2 = 15 min)
E (1.0 p,M uPA; T1/2 15 min)
Continuous infusion
C (0.1 ,uM tPA + 0.1 ,uM uPA)
C (0.1 ,uM tPA + 1.0 ,uM uPA)
C (1.0,uM tPA + 0.1 ,uM uPA)
C (1.0 ,uM tPA + 1.0 ,uM uPA)
C (5.0 ,uM tPA + 0.1 ,uM uPA)
C (0.1 ,uM tPA + 5.0 ,uM uPA)
Bolus + continuous infusion
5 min B (1.0 ,uM tPA) + C (0.1 ,uM tPA)
5 min B (1.0 ,uM tPA) + C (0.1 ,uM uPA)
5 min B (1.0 ,uM uPA) + C (0.1 ,uM tPA)
5 min B (1.0 ,uM uPA) + C (0.1 ,uM uPA)
5 min B (5.0 ,uM tPA) + C (0.1 ,uM uPA)
5 min B (5.0 ,uM uPA) + C (0.1 ,uM tPA)
Double bolus infusion
5 min B (1.0 ,uM tPA) + S min wait
+ 5 min B (1.0 ,uM tPA)
S min B (1.0 ,uM tPA) + 10 min wait
+ S min B (1.0 ,.M tPA)
S min B (1.0 p,M uPA) + 5 min wait
+ S min (1.0 ,uM uPA)
5 min B (1.0 ,uM uPA) + 10 min wait
+ 5 min B (1.0 A.M uPA)
5 min B (1.0 ,uM tPA) + 5 min wait
+ 5 min B (1.0 ,uM uPA)
5 min B (1.0 ,uM tPA) + 10 min wait
+ 5 min B (1.0 ,uM uPA)
5 min B (1.0 p,M uPA) + 5 min wait
+ S min B (1.0 ,uM tPA)
5 min B (1.0 ,uM uPA) + 10 min wait
+ S min B (1.0 ,uM tPA)
33.43
23.03
18.33
22.33
22.27
28.6
21.4
18.3
21.17
21.17
>1500*
111.0
67.1
23.4
21.7
22.7
21.4
25.5
20.8
21.9
19.4
18.2
18.1
22.9
22.3
20.9
21.3
28.5
18.1
22.9
23.0
21.3
21.4
22.9
23.1
21.2
21.3
* 1666 min to achieve 42.7% lysis.
The time needed to achieve 50% overall clot lysis is predicted for various
administration regimes with 2.2 j.LM glu-plg in the permeating fluid (B =
Bolus; C = Constant continuous infusion; E = Exponential decay given by
C. * exp(-t/Tl/2), where T12 is the half-life of the agent at the clot inlet).
Simulations were for lysis of a flow-compacted (220 ,uM fibrin), coarse
(Rf. = 250 nm) clot, equilibrated with 2.2 ,uM glu-plg (Cp,g = 0.940 ,uM;
Cf,g = 1.856 ,uM) prior to lysis. The permeation was driven by AP/L = 50
mm-Hg/cm in all simulations (initial Pe = 421 and permeation velocity =
2.10 X 10-4 cm/s).
5-fold decrease in T50. It has beeen pointed out earlier (Fig.
6 E) that the fluid phase concentration of plasmin reaches
high levels for lysis with 1 ,M uPA. Consequently, increas-
ing the rate of adsorption leads to higher levels of bound
plasmin and therefore higher lysis reates. For tPA-mediated
lysis, the plasmin tends to remain bound to fibrin and there-
fore alteration of the rate of adsorption does not affect the rate
of lysis in any significant way.
In other simulations, increasing the k2 of the plasminogen
activation reaction by either tPA or uPA led to more rapid
lysis. For example, increasing the k2 of plasminogen acti-
vation by tPA from the wildtype value of 0.1 s-1 to 100 s-1
reduced the T50 by half. The gains were similar to the gains
seen by increasing the dose of tPA or uPA delivered into a
clot. Reducing the Km of tPA for bound plasminogen from
the wildtype value of 0.16 ,uM to 0.1 nM had no effect on
lytic efficiency.
DISCUSSION
Considerable debate still exists on what properties the ideal
plasminogen activator should have (Haber, 1989). Some
workers believe strong binding of fibrin is essential. Fibrin
specificity is considered the main advantage of tPA, poten-
tially leading to clot-specific dissolving power. However,
significant reduction of circulating fibrinogen levels is found
in patients treated with recombinant tPA, indicating systemic
plasminogen activation. Fibrinogenolysis also can occur
with the use of urokinase and streptokinase which lack the
ability to bind fibrin. Other workers contend that a cocktail
of prourokinase and tPA is most effective. The advent of
thrombolytic therapy has driven the development of second
and third generation recombinant plasminogen activators.
Prediction of clinical efficacy using animal models or in vitro
data is still difficult, and optimization of thrombolytic
therapy requires human clinical studies. From our numerical
calculations of fibrinolysis, we predict that
1. Penetration of tPA or uPA into a clot structure by
pressure-driven permeation must occur during thrombolytic
therapy, and is the dominant mode of transport. If diffusion
were the only mechanism of transport, lysis would require
many hours or days to occur. The penetration rate of the lytic
agent is a major regulator of the time needed to dissolve a
clot.
2. The penetration of tPA into the clot is slowed by its
strong binding to the fibrin. The transport of tPA (as well as
lys-plasminogen and plasmin) as it moves through a clot is
not at local equilibrium since adsorption is relatively fast and
strong while desorption is slow.
3. In agreement with many experimental investigations,
the prevailing concentration of plasminogen prebound to the
clot or perfused into the clot has a strong impact on the lysis
rates. The use of tPA and uPA together may also be advan-
tageous due to transport phenomena where uPA provides for
a leading wave of lysis moving with the permeation front,
while tPA leads to strong lysis of the front of the clot.
4. The long clots of the venous system have a relatively
low AP/L across them which may make them resistant to
thrombolytic therapy. Improvement of lytic therapies for
these clots should focus on improvement of transport pro-
cesses. Long clots extending the length of a large vessel
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would most likely benefit from reduced fibrin binding of the
plasminogen activator. In short clots of less than a centimeter
in length, fibrin binding capacity may be beneficial and pen-
etration distances short enough, to advocate tPA usage.
The measurement of plasminogen activation rates and clot
solubilization rates on whole clots when conducted without
permeation may lead to apparent kinetic constants which
may be at least an order of magnitude too slow due to dif-
fusion limits. To avoid these transport limitations, the mea-
surement of intrinsic kinetics of fibrinolysis requires
mechanically-dispersed fibrin, gradientless reactions in well
mixed systems, or very small diffusion lengths such as those
found in fibrin films. Diffusion limits may exist in experi-
ments which use preformed fibrin clots exposed to a bulk
solution of a lytic cocktail, even if that cocktail is well mixed
outside the clot. With pressure driven permeation, the full
potential of the lytic agents as well as other phenomena can
be studied as they likely exist in vivo.
From these simulations, some generalizations can be made
about the protein engineering of agents for arterial throm-
bolytic therapy. First, ultrahigh fibrin affinity uPA-IgG chi-
merics (Kd < 100 nm) may prove less useful in vivo due to
poor clot penetration. This limitation of a uPA-IgG chimeric
would not necessarily be observed in vitro unless experi-
ments with permeation were conducted. Chimerics such as
uPA active site plus kringle 1 and 2 of tPA may prove useful
for targeting uPA to a clot without excessively hindering its
ability to penetrate into the clot. There is no gain in enhancing
or reducing the fibrin binding avidity of tPA for use of the
agent under conditions of permeation.
Earlier modeling work by Zidansek and Blinc (1991)
treated uPA-mediated lysis of fibrin as a homogeneous prob-
lem with no distinction between species in the fluid phase or
in the fibrin phase. This approach is not suitable for tPA-
mediated lysis which is distinctly heterogeneous. Addition-
ally, the important effects of plasminogen binding to the clot
can not be taken into account with a homogeneous approach.
We have made an effort to describe quantitatively the: (i)
time evolving fibrin fiber and fibrin density, (ii) adsorption
and desorption phenomena under nonequilibrium conditions,
(iii) pressure-induced permeation, and (iv) the kinetics of
each individual reaction. These important aspects have not
been considered in the analysis of Zidansek and Blinc (1991).
To our knowledge, this is the first model to account for these
four qualitatively and quantitatively important phenomena in
fibrinolysis. The earlier modeling efforts of Sobel et al.
(1984) and Tiefenbrunn et al. (1986) predict the pharmaco-
dynamics of fibrinolytic mediators in the circulation but
make no prediction of actual clot lysis as a function of clot
structure or clot composition. The predictions from their
model would serve as the initial and boundary conditions for
our system of equations.
Very little data exists in the literature where inner clot
permeation is controlled or measured during thrombolysis. In
work by Blinc et al. (1991), it was reported that a pressure
of 27 mm-Hg led to rapid collapse of a fibrin gel during lysis.
This high pressure (we estimate the Peclet number to be
about 10,000 to 20,000) led to flow-induced collapse of the
gel. Flow-induced collapse of a fibrin network is a macro-
scopic observation of a micro-rheological phenomena which
is nearly impossible to quantitatively relate to the actual ki-
netic events of fibrinolysis. In our in vitro measurements of
fibrin gels exposed to pure plasmin at APIL = 3.5 mm-Hg/
cm-clot, we have observed that a lysis front can proceed in
a stable fashion for several hours without collapse of the gel
structure. This preliminary experimental observation is con-
sistent with our predictions of a stable albeit steep lysis pro-
file which moves forward with time (as seen in Fig. 4). In
comparisons of the model to experiments for lysis of fine and
coarse gels with continuous infusion of 1 ,uM plasmin, we
have found our simulation to consistently over predict the
lysis rate (Fig. 11) even when lysis was constrained to the
surface of the fiber (i.e., K = 1). This may be due to our use
of enzyme rates for plasmin cleavage of chromogenic sub-
strates (as compared to the more complex fibrin substrate).
In these perfusion experiments with high plasmin concen-
trations, fine and coarse gels were found to lyze at similar
rates. Given the large number of kinetic constants and the
uncertainty of certain parameters in our model, validation
and improvement of the present model will require many
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FIGURE 11 Comparison of model predictions with experiments for lysis
of non-cross-linked fine and coarse fibrin gels subjected to continuous in-
fusion of 1 ,uM plasmin. Fibrin gels of 2 cm length were polymerized [3.0
mg/ml fibrinogen (Kabi) with 1 U/ml thrombin (Sigma) for 24 h at 2.5 mM
CaCl2 and 0.1 (fine gels) or 0.3 M NaCl (coarse gels)] and then lyzed with
plasmin (Sigma) according to the methods of Carr and Hardin (1987) using
constant pressure drops from 0.369 to 3.69 mm-Hg/cm-clot. The precise
position of the lysis front of each gel was observed microscopically at vari-
ous time intervals (for calculation of the pseudo steady-state velocity of the
lysis front) while the perfusion velocity was measured. The experimentally
determined perfusion velocity served as an input into the simulation (as
opposed to the pressure drop since several data points were derived from
a single experiment). The position of 50% lysis was used as the marker of
the lysis front in the simulations. Coarse gels had fibers which were just
visible by contrast-enhanced DIC microscopy suggesting that the initial
fiber radius was between 100 and 250 nm. Nominal values for the initial
fiber radius (Rf0) for fine gels were set at 10 and 25 nm in the simulations.
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experiments. At this point, we propose that fibrinolysis can
be described quantitatively using a convection/diffusion/
reaction model. Such a model will be useful in optimizing
thrombolytic therapies and in interpreting experimental data
to identify molecular mechanisms and test hypotheses.
In future work, the inhibition reactions of PAI-1 and a2-
antiplasmin will be included without major modification of
the model. The biochemical role of binding sites on platelet
surfaces can be treated by uniformly distributing the sites
(with associated Kd's) over the fibrin phase. However, plate-
lets and RBC play a role in the hydrodynamics of the clot by
reducing the void volume of the clot available for permeation
and by altering the fiber structure. Certainly more complex
biochemical and kinetic scenarios for plasminogen activation
can be incorporated into the governing transport equations.
In clots with multiple layers, it is possible that channeling
through paths of least resistance leads to some clinical ad-
vantage. Simulation of reperfusion achieved by cannulation
of a clot would require solution of the transient, two dimen-
sional (radial and axial) problem which would require ac-
curate prediction of the velocity profile near the wall.
At present the model has no adjustable parameters and
uses a single phenomenological parameter (-y) estimated
from experiment. The kinetic parameters were evaluated
from data obtained with purified systems of mechanically
dispersed fibrin. This choice was made in order to avoid
analyzing binding data obtained with fibrin gels which may
contain diffusional artifacts. Few direct measurements have
been made to evaluate the forward and reverse rate constants
for different species adsorbing to fibrin in the absence of
diffusion limitations. Also, plasminogen activation kinetics
are well studied, however very little data are available for
intrinsic rate constants of plasmin cleavage of real fibrin
cleavage sites. The formulation of the cleavage rate (Eq. 10)
as well as the solubilization rate (Eq. 12) was approximate,
but does contain the important feature that the rate is pro-
portional to the bound plasmin concentration and the
volume-averaged available site concentration. The kinetics
of fibrin solubilization by plasmin are not well studied due
to the complexity of the phenomena, and are likely modu-
lated by fiber structure and extent of fiber crosslinking.
Currently, the theoretical and experimental basis for quan-
titatively predicting either hindered diffusion or flow-
enhanced dispersion of species which adsorb and react with
aperiodic random fibrous media is not complete. In this
sense, our formulation of these contributions in Eqs. 3 and
4 has some limitations. However, greater gains in under-
standing the role of transport processes in fibrinolysis are
likely to be achieved through a more accurate knowledge of
the specific permeability of real clots since arterial throm-
bolysis is a convection-dominated problem with a moderate
to high Peclet number. Also, direct measurements of the spe-
cific permeability and histology/biochemistry of real blood
clots formed in the arterial and venous system or formed
under controlled in vitro flow conditions will advance the
quantitative understanding and predictive optimization of fi-
brinolysis and thrombolytic therapy.
APPENDIX
In order to quantify the number of binding sites accessible on the fiber
surfaces within a given region of the fibrin clot, the total length of fibers
initially in the clot was evaluated. Since fibrin fibers have a relatively uni-
form radius Rf, the total length of fibers is related to the fiber density (Pfiber),
the clot density (cl., = gr-fibrin/VolT) and the clot total volume, VOlT (cm3).
The total length of fibers in the gel is given as
LT = ( 10)( nm C3)/ (VoT) for LT and Rfo[=] nm.TPl)- pfil,er('fRfo2) (Tlt
If lysis proceeds from the outside of the fiber inward, the total length of fibrin
fibers in the gel is constant with time (Fig. 1). The length of fiber within
a volume element AV = AAx is given as
AX
Ay L-clot (LT)
Since the total clot volume is VOT = A-L-clot, the length of fiber per unit
volume (nm/cm3) is
LAv LT
AWV VOlT
To evaluate the binding sites on the outer surface of each fiber, it
was necessary to know the number of protofibrils on the outer surface of
each fiber. The total number of protofibrils N contained in a fiber bundle
of Rf can be calculated from the fiber density (Carr and Hermans, 1978)
as follows:
0.28 gr-fibrinPfiber ml-fiber
(MW%pr/Na )N( 2 monomer/45 nm)(L-fibril)
Pfiber = rR2 ( 10j21cm3/nM3) (L-fiber)
Since L-fibril is equal to L-fiber for fibrils oriented in the direction of the
fiber, the number of protofibrils in a fiber is given as
N = (0.035061)Rf2 for Rf[=]nm
and the protofibril density po = N/(QRf2) in the fiber is
p. = 0.01116 fibrils/nm2 of fiber cross-sectional area.
According to Carr and Hermans (1978) the volume of water in the fiber is
five times the volume of the fibrin in the fiber. Thus, the porosity of the
fiber Efiber is 0.8. The fiber porosity is a volume ratio corresponding to
Eiiber = 1 - (fibril volume/fiber volume) = 1 - N(irr02)/(-Rfr2) = 0.8
Thus, an estimate of the protofibril radius excluding all water is calcu-
lated (by substitution of po into the above equation) to be 2.390 nm which
is exactly consistent with the molecular volume of a fibrinogen molecule
(density of fibrinogen is 1.39 gr/cm3). The number of fibrils on the out-
side of a fiber of radius Rf is defined as the number fibrils which reside
on the outer radius of the fiber within one protofibril radius:
2,r Rf+ro
m(Rf) = J por drdO = [4npOrOJRf
For relaxation of the steric hindrance constraint, the number of protofibils
which reside within K ro of the outer radius Rf of the fiber can be
expressed as
f2arfRf+ro
m(Rf) = pr dr dO = 7p0[2Rfr0(1 + K) + r02(l - K2)]
ORI-or0
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This is equivalent to n shells of protofibril which participate in fibrinoly-
sis where n = (K + 1)/2. To evaluate the local fiber radius R(x', t')
knowing the amount (,uM) of fibrin that has been lyzed off the outside of
the fibers, the lysis L(x', t') is related to the number of fibrils (and
equivalent volume) of the fiber degraded. Rearrangement of the equation
below yields Eq. 14 in the text.
L(x',t)= I~- Rf(XI, t2p LT 2 monomers 1 106,pmol/mol
L(X',t') [1ROxf( t JO VOl 45 nm N., 10-I I/cm'
The local bulk porosity can be defined with respect to the local fiber di-
ameter since the length of fiber per unit volume remains constant during
lysis:
V fiinAV LAv /02 cm3NE(X, t) = 1 - solid = 1 - TR f(x',t)2.- 310-21 nm)
The local specific permeability k(x, t) is calculated from E(x, t) and
R(x, t) using Eq. 2. At any given time t', the overall specific permeability
can be evaluated as the inverse of the total resistivity by integrating the
local resistivity [k(x, p)]-l over the length of the clot.
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